Noninvasive Technique and High Flow Nasal Oxygen in Respiratory Failure
NCT: NCT07521254 · RECRUITING
Brief Summary
After obtaining Institutional Ethical Committee approval of Faculty of Medicine, Minia University and written informed consent from patients or first- degree relatives, this prospective randomized non-blind comparative study will be conducted in adult intensive care unit (ICU) of Anesthesia, Intensive Care and Pain management department Minia university hospital over a period from September 2025 to April 2026. This study is designed to compare the effectiveness of two protocols of sequential use of High Flow Nasal Cannula (HFNC) and noninvasive ventilation (NIV) versus NIV alone in patients with Acute Respiratory failure (ARF) admitted to the intensive care unit (ICU). The study will include 75 patients of both sexes, classified as ASA class Ⅰ-ⅠⅠⅠ, divided into three groups with 25 patients in each group.
Frequently Asked Questions
What is Noninvasive Technique and High Flow Nasal Oxygen in Respiratory Failure?
Noninvasive Technique and High Flow Nasal Oxygen in Respiratory Failure is a clinical trial registered under NCT07521254. Current status: RECRUITING.
What is the status of NCT07521254?
The current status of NCT07521254 (Noninvasive Technique and High Flow Nasal Oxygen in Respiratory Failure) is: RECRUITING.
When did Noninvasive Technique and High Flow Nasal Oxygen in Respiratory Failure start?
Noninvasive Technique and High Flow Nasal Oxygen in Respiratory Failure started on 2025-06-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.